Marcela Díaz Rivadeneira

Dr. Marcela Díaz Rivadeneira


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
AQAlejandra Mondragón Quiguanas
Alejandra Mondragón Quiguanas
JSJorge Iván Montoya Salazar Momtoya Salazar
Jorge Iván Montoya Salazar Momtoya Salazar
JMJuan Camilo Mosquera-Hernandez
Juan Camilo Mosquera-Hernandez
MAMargareth Zuluaga Aricapa
Margareth Zuluaga Aricapa
CFCarlos Eduardo Pinzón Flórez
Carlos Eduardo Pinzón Flórez
MRMarcela Díaz Rivadeneira
Marcela Díaz Rivadeneira
Background: Antimicrobial resistance is a threat that increases morbidity and mortality. This cross-sectional study aimed to describe the profile of priority antimicrobial-resistant pathogens and to analyze the behavior of multidrug-resistant tuberculosis (MDR-TB) in the Santiago de Cali District, Colombia. Methods: researchers compiled information from data provided by healthcare institutions, the National Public Health Surveillance System, and laboratory-based surveillance using the World Health Organization’s WHONET v.5.6 software. Univariate statistical analysis described trends in pathogen resistance, and multivariate analysis analyzed the behavior of MDR-TB. Results: Among Gram-negative bacteria, high levels of carbapenem resistance were observed in A. baumannii (84% aztreonam resistance) and in K. pneumoniae (63%). P. aeruginosa exhibited elevated multidrug resistance, consistent with extensive antimicrobial selective pressure. MDR-TB exhibited a high burden of resistance, reaching 96%, with projections indicating a potential increase driven by monoresistance and resistance to rifampicin. Patients with drug-resistant tuberculosis who were HIV-positive or experiencing homelessness had a significantly higher likelihood of hospitalization (OR 5.59; 95% CI 3.09–10.11 and OR 2.94; 95% CI 1.48–5.81, respectively) and mortality (OR 3.34; 95% CI 1.72–6.49 and OR 2.59; 95% CI 1.16–5.79, respectively). Conclusions: The expansion of resistance mechanisms suggests sustained selective pressure, underscoring the need for strategies to optimize antibiotics.